Inherited thrombophilic risk factors in a large cohort of individuals referred to italian thrombophilia centers: Distinct roles in different clinical settings

Haematologica

Volumn 86, Issue 6, 2001, Pages 634-639

  Margaglione, M ^a   Brancaccio, V ^a   Ciampa, A ^a   Papa, M L ^a   Grandone, E ^a   Di Minno, G ^a  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

Author keywords

Inherited thrombophilia; Screening program; Vein thrombosis

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL FEATURE; DEEP VEIN THROMBOSIS; FEMALE; GENETIC RISK; GENETIC SCREENING; HUMAN; INHERITANCE; MAJOR CLINICAL STUDY; MALE; OCCLUSIVE CEREBROVASCULAR DISEASE; PRESCHOOL CHILD; RISK ASSESSMENT; SCHOOL CHILD; THROMBOPHILIA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FAMILY HEALTH; FEMALE; HUMANS; ITALY; MALE; MASS SCREENING; RETROSPECTIVE STUDIES; RISK FACTORS; THROMBOEMBOLISM; THROMBOPHILIA; VENOUS THROMBOSIS;

EID: 0034950002     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. The epidemiology of diagnosed pulmonary embolism and deep venous thrombosis in the elderly
2. Inherited thrombophilia
3. Mutation in blood coagulation factor V associated with resistance to activated protein C
4. Physiological anticoagulation. Resistance to activated protein C and venous thromboembolism
5. A common genetic variation in the 3'untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis
6. The prothrombin gene G20210A variant: Prevalence in a U.K. anticoagulant clinic population
7. Increased risk of venous thrombosis in carriers of the prothrombin A20210 gene variant
8. Activated protein C resistance as an additional risk factor for thrombosis in protein C-deficient families
9. Incidence of activated protein C resistance caused by the ARG 506 GLN mutation in factor V in 113 unrelated symptomatic protein C-deficient patients
10. Factor V Leiden: An additional risk factor for thrombosis in protein S deficient families?
11. Factor V Leiden (FV R506Q) in families with inherited antithrombin deficiency
12. Co-inheritance of the 20210A allele of the prothrombin gene increases the risk of thrombosis in subjects with familial thrombophilia
13. The heterozygous 20210 G/A prothrombin genotype is associated with early venous thrombosis in inherited thrombophilias and is not increased in frequency in artery disease
14. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation
15. Coexistence of factor V Leiden and factor II A20210 mutations and recurrent venous thromboembolism
16. Resistance to activated protein C in an unselected population of patients with pulmonary embolism
17. Risk factors profiles in patients with different clinical manifestations of venous thromboembolism
18. Low prevalence of factor V:Q506 in 41 patients with isolated pulmonary embolism
19. Prevalence of factor V Leiden in young adults with retinal vein occlusion
20. Validated questionnaire for the identification of previous personal or familial venous thromboembolism
21. Coagulation studies, factor V Leiden, and anticardiolipin antibodies in 40 cases of cerebral venous thrombosis
22. High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives
23. Risk factors for deep venous thrombosis of the upper extremities
24. Factor V Leiden and prothrombin 20210 A mutations in patients with central and branch retinal vein occlusion
25. Prevalence of factor V Leiden in patients with retinal vein occlusion
26. Activated protein C resistance and anticoagulant proteins in young adults with central retinal vein thrombosis
27. Portal vein thrombosis with ruptured oesophageal varices as presenting manifestation of hereditary protein C deficiency
28. The incidence of protein C deficiency in thrombosis-related portal hypertension
29. Inherited coagulation disorders in cirrhotic patients with portal vein thrombosis
30. Factor V Leiden and fatal pulmonary embolism
31. Genetic susceptibility to venous thrombosis
32. Inherited thrombophilia: Pathogenesis, clinical syndromes, and management
33. Venous thrombosis: A multicausal disease